148 related articles for article (PubMed ID: 32429642)
1. Association of HDAC8 Expression with Pathological Findings in Triple Negative and Non-Triple Negative Breast Cancer: Implications for Diagnosis.
Menbari MN; Rahimi K; Ahmadi A; Mohammadi-Yegane S; Elyasi A; Darvishi N; Hosseini V; Abdi M
Iran Biomed J; 2020 Sep; 24(5):288-94. PubMed ID: 32429642
[TBL] [Abstract][Full Text] [Related]
2. miR-483-3p suppresses the proliferation and progression of human triple negative breast cancer cells by targeting the HDAC8>oncogene.
Menbari MN; Rahimi K; Ahmadi A; Mohammadi-Yeganeh S; Elyasi A; Darvishi N; Hosseini V; Abdi M
J Cell Physiol; 2020 Mar; 235(3):2631-2642. PubMed ID: 31508813
[TBL] [Abstract][Full Text] [Related]
3. Histone deacetylase 8 triggers the migration of triple negative breast cancer cells via regulation of YAP signals.
An P; Li J; Lu L; Wu Y; Ling Y; Du J; Chen Z; Wang H
Eur J Pharmacol; 2019 Feb; 845():16-23. PubMed ID: 30582912
[TBL] [Abstract][Full Text] [Related]
4. Histone deacetylase inhibitors suppress mutant p53 transcription via HDAC8/YY1 signals in triple negative breast cancer cells.
Wang ZT; Chen ZJ; Jiang GM; Wu YM; Liu T; Yi YM; Zeng J; Du J; Wang HS
Cell Signal; 2016 May; 28(5):506-515. PubMed ID: 26876786
[TBL] [Abstract][Full Text] [Related]
5. Effect of histone deacetylase 8 gene deletion on breast cancer cellular mechanism in vitro and in vivo study.
Rahmani G; Moloudi MR; Amini R; Rahimi K; Fathi F; Abdi M; Najafi R
Life Sci; 2022 Dec; 311(Pt A):121156. PubMed ID: 36356894
[TBL] [Abstract][Full Text] [Related]
6. Suberoylanilide hydroxamic acid (SAHA) promotes the epithelial mesenchymal transition of triple negative breast cancer cells via HDAC8/FOXA1 signals.
Wu S; Luo Z; Yu PJ; Xie H; He YW
Biol Chem; 2016 Jan; 397(1):75-83. PubMed ID: 26431101
[TBL] [Abstract][Full Text] [Related]
7. Engrailed 1 overexpression as a potential prognostic marker in quintuple-negative breast cancer.
Kim YJ; Sung M; Oh E; Vrancken MV; Song JY; Jung K; Choi YL
Cancer Biol Ther; 2018 Apr; 19(4):335-345. PubMed ID: 29333926
[TBL] [Abstract][Full Text] [Related]
8. Use of histone deacetylase 8 (HDAC8), a new marker of smooth muscle differentiation, in the classification of mesenchymal tumors of the uterus.
de Leval L; Waltregny D; Boniver J; Young RH; Castronovo V; Oliva E
Am J Surg Pathol; 2006 Mar; 30(3):319-27. PubMed ID: 16538051
[TBL] [Abstract][Full Text] [Related]
9. MiR-216b-5p inhibits cell proliferation in human breast cancer by down-regulating HDAC8 expression.
Menbari MN; Rahimi K; Ahmadi A; Elyasi A; Darvishi N; Hosseini V; Mohammadi-Yeganeh S; Abdi M
Life Sci; 2019 Nov; 237():116945. PubMed ID: 31605710
[TBL] [Abstract][Full Text] [Related]
10. The clinical significance of histone deacetylase-8 in human breast cancer.
Rahmani G; Sameri S; Abbasi N; Abdi M; Najafi R
Pathol Res Pract; 2021 Apr; 220():153396. PubMed ID: 33691240
[TBL] [Abstract][Full Text] [Related]
11. Non-epigenetic function of HDAC8 in regulating breast cancer stem cells by maintaining Notch1 protein stability.
Chao MW; Chu PC; Chuang HC; Shen FH; Chou CC; Hsu EC; Himmel LE; Huang HL; Tu HJ; Kulp SK; Teng CM; Chen CS
Oncotarget; 2016 Jan; 7(2):1796-807. PubMed ID: 26625202
[TBL] [Abstract][Full Text] [Related]
12. Alterations in histone deacetylase 8 lead to cell migration and poor prognosis in breast cancer.
Hsieh CL; Ma HP; Su CM; Chang YJ; Hung WY; Ho YS; Huang WJ; Lin RK
Life Sci; 2016 Apr; 151():7-14. PubMed ID: 26926079
[TBL] [Abstract][Full Text] [Related]
13. Discovery of highly potent HDAC8 PROTACs with anti-tumor activity.
Zhao C; Chen D; Suo F; Setroikromo R; Quax WJ; Dekker FJ
Bioorg Chem; 2023 Jul; 136():106546. PubMed ID: 37098288
[TBL] [Abstract][Full Text] [Related]
14. Expression of glucose-regulated protein 78 as prognostic biomarkers for triple-negative breast cancer.
Yang C; Zhang Z; Zou Y; Gao G; Liu L; Xu H; Liu F
Histol Histopathol; 2020 Jun; 35(6):559-568. PubMed ID: 31745967
[TBL] [Abstract][Full Text] [Related]
15. Co-targeting poly(ADP-ribose) polymerase (PARP) and histone deacetylase (HDAC) in triple-negative breast cancer: Higher synergism in BRCA mutated cells.
Marijon H; Lee DH; Ding L; Sun H; Gery S; de Gramont A; Koeffler HP
Biomed Pharmacother; 2018 Mar; 99():543-551. PubMed ID: 29902865
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of circ-UBAP2 predicts poor prognosis and promotes triple-negative breast cancer progression through the miR-661/MTA1 pathway.
Wang S; Li Q; Wang Y; Li X; Wang R; Kang Y; Xue X; Meng R; Wei Q; Feng X
Biochem Biophys Res Commun; 2018 Nov; 505(4):996-1002. PubMed ID: 30314706
[TBL] [Abstract][Full Text] [Related]
17. Morphological and Semiquantitative Kinetic Analysis on Dynamic Contrast Enhanced MRI in Triple Negative Breast Cancer Patients.
Gigli S; Amabile MI; David E; De Luca A; Grippo C; Manganaro L; Monti M; Ballesio L
Acad Radiol; 2019 May; 26(5):620-625. PubMed ID: 30145205
[TBL] [Abstract][Full Text] [Related]
18. SIRT1 induces tumor invasion by targeting epithelial mesenchymal transition-related pathway and is a prognostic marker in triple negative breast cancer.
Jin MS; Hyun CL; Park IA; Kim JY; Chung YR; Im SA; Lee KH; Moon HG; Ryu HS
Tumour Biol; 2016 Apr; 37(4):4743-53. PubMed ID: 26515337
[TBL] [Abstract][Full Text] [Related]
19. Cloning and characterization of a novel human class I histone deacetylase that functions as a transcription repressor.
Hu E; Chen Z; Fredrickson T; Zhu Y; Kirkpatrick R; Zhang GF; Johanson K; Sung CM; Liu R; Winkler J
J Biol Chem; 2000 May; 275(20):15254-64. PubMed ID: 10748112
[TBL] [Abstract][Full Text] [Related]
20. Changes in histone deacetylase (HDAC) expression patterns and activity of HDAC inhibitors in urothelial cancers.
Niegisch G; Knievel J; Koch A; Hader C; Fischer U; Albers P; Schulz WA
Urol Oncol; 2013 Nov; 31(8):1770-9. PubMed ID: 22944197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
